News Posts List
Prognostic stratification of patients with advanced renal cell carcinoma
04/14/2010
The treatment paradigm in advanced renal cell carcinoma (RCC) has changed in the recent years. Sunitinib has been established as a new standard for first-line therapy. We studied the prognostic significance of baseline characteristics and we compared the risk stratification with the established Memorial Sloan Kettering Cancer Center (MSKCC) model.
Early 21st Century renal cell carcinoma
04/14/2010
Individuals involved in the management of patients with small renal masses should acknowledge the role and the importance of active surveillance in older populations (aged >75 years) and minimally invasive ablative therapies. These new therapeutic strategies should be inculcated during medical training and practice so that they may become just as embedded as the emphasis on the oncologic outcome of standard treatment.
Combined classical cytogenetics and microarray-based genomic copy number analysis reveal frequent 3;5 rearrangements in clear cell renal cell carcinoma
04/14/2010
Karyotypic analysis and genomic copy number analysis with single nucleotide polymorphism (SNP)-based microarrays were compared with regard to the detection of recurrent genomic imbalances in 20 clear cell renal cell carcinomas (ccRCCs).
WSJ: The Separation of Health and State
04/13/2010
What happens when all medical decisions are political.
VIDEO: Association Board Chair Sarah Wise Miller
04/13/2010
A few years ago, patients diagnosed with advanced kidney cancer had limited treatment options. However, in recent years, innovative targeted therapies have been developed that have helped countless patients delay the progression of the disease.
VIDEO: Living With Kidney Cancer
04/13/2010
Hallucinogens Have Doctors Tuning In Again
04/13/2010
As a retired clinical psychologist, Clark Martin was well acquainted with traditional treatments for depression, but his own case seemed untreatable as he struggled through chemotherapy and other grueling regimens for kidney cancer. Counseling seemed futile to him. So did the antidepressant pills he tried.
Keryx Biopharmaceuticals, Inc.
04/13/2010
Keryx declared the results of the clinical activity of KRX-0401 (perifosine), the company´s Akt-inhibitor for cancer, to be used as a treatment for advanced renal cell carcnoma.
EAU Congress in Barcelona tops attendance registrations
04/13/2010
The congress will also tackle some of the most controversial issues in urology and the EAU's Scientific Committee has prepared a programme that covers a long list of urological topics ranging from paediatrics, bladder cancer, female urology, renal cell carcinoma, reconstruction and functional urology, benign prostatic obstruction, stones and minimal invasive therapy, to name a few. The Kidney Cancer Association is represented at this meeting through the participation of its board member and past chairman, Paula E. Bowen.
The genetic link
04/13/2010
HNPCC also raises the risk of other cancers, including ovarian, stomach, pancreatic and kidney cancer.